Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity
Lirit N. Franks, Benjamin M. Ford, Paul L. Prather
Frontiers in Pharmacology (2016) Vol. 7
Open Access | Times Cited: 25

Showing 25 citing articles:

Future Aspects for Cannabinoids in Breast Cancer Therapy
Terézia Kisková, Felicitas Mungenast, Mária Suváková, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 7, pp. 1673-1673
Open Access | Times Cited: 118
Sex differences and the endocannabinoid system in pain
Henry Blanton, Robert C. Barnes, Melissa C. McHann, et al.
Pharmacology Biochemistry and Behavior (2021) Vol. 202, pp. 173107-173107
Open Access | Times Cited: 97
Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?
Francesca Rossi, Chiara Tortora, Maura Argenziano, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 3809-3809
Open Access | Times Cited: 77
Cannabinoids and Hormone Receptor-Positive Breast Cancer Treatment
Luka Dobovišek, Fran Krstanović, Simona Borštnar, et al.
Cancers (2020) Vol. 12, Iss. 3, pp. 525-525
Open Access | Times Cited: 41
Mechanism of regulating macrophages/osteoclasts in attenuating wear particle-induced aseptic osteolysis
Zhaoyang Yin, Ge Gong, Xinhui Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER+ breast cancer cells: Impact on aromatase and steroid receptors
Cristina Amaral, Fabien Marc Trouille, Cristina Ferreira Almeida, et al.
The Journal of Steroid Biochemistry and Molecular Biology (2021) Vol. 210, pp. 105876-105876
Closed Access | Times Cited: 28
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review
Aleksandra Zielińska, Piotr Eder, Jacek Karczewski, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Endocannabinoid System and Metabolism: The Influences of Sex
Isabel Forner-Piquer, Christian Giommi, Fiorenza Sella, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11909-11909
Open Access | Times Cited: 3
Cannabidiol as a Promising Adjuvant Therapy for Estrogen Receptor-Positive Breast Tumors: Unveiling Its Benefits with Aromatase Inhibitors
Cristina Ferreira Almeida, Natércia Teixeira, Maria João Valente, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2517-2517
Open Access | Times Cited: 8
Supraphysiologic doses of 17β-estradiol aggravate depression-like behaviors in ovariectomized mice possibly via regulating microglial responses and brain glycerophospholipid metabolism
Ming Li, Jing Zhang, Wendi Chen, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Cannabinoids Receptors in COVID-19: Perpetrators and Victims
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Αθανάσιος Αλεξίου, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 34, pp. 3832-3845
Closed Access | Times Cited: 8
Sex differences in cocaine-associated memory: The interplay between CB1, mGluR5, and estradiol
Heng-Ai Chang, Wen Dai, Sherry Shu‐Jung Hu
Psychoneuroendocrinology (2021) Vol. 133, pp. 105366-105366
Closed Access | Times Cited: 11
Phytocannabinoids as Chemotherapy Adjuncts – a User Guide
Gerhard Nahler
(2024)
Open Access | Times Cited: 1
Phytocannabinoids as Chemotherapy Adjuncts—A Review for Users
Gerhard Nahler
Onco (2024) Vol. 4, Iss. 4, pp. 287-321
Open Access | Times Cited: 1
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development
Benjamin M. Ford, Lirit N. Franks, Anna Radomińska‐Pandya, et al.
PLoS ONE (2016) Vol. 11, Iss. 12, pp. e0167240-e0167240
Open Access | Times Cited: 10
Identification of CB1 Ligands among Drugs, Phytochemicals and Natural-Like Compounds: Virtual Screening and In Vitro Verification
Adam Stasiulewicz, Anna Leśniak, Piotr Setny, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 20, pp. 2991-3007
Open Access | Times Cited: 7
Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers
Ji‐Sun Yeun, Hyesu Kan, Minyu Lee, et al.
Translational and Clinical Pharmacology (2020) Vol. 28, Iss. 2, pp. 102-102
Open Access | Times Cited: 4
Effect of combining CBD with standard breast cancer therapeutics
Luka Dobovišek, Metka Novak, Fran Krstanović, et al.
Advances in Cancer Biology - Metastasis (2022) Vol. 4, pp. 100038-100038
Open Access | Times Cited: 3
From biosynthesis to therapeutics: A comprehensive review on varied functions of estrogen and selective estrogen receptor modulators
Akrati Sant, Imran Ahmad, Sonika Bhatia, et al.
Journal of Molecular Structure (2024) Vol. 1327, pp. 141197-141197
Closed Access
Cannabinoid receptor subtype 2 (CB2R): Features and targets for medical applications
Marialessandra Contino, Carmen Abate, Nicola Antonio Colabufo, et al.
Elsevier eBooks (2023), pp. 319-333
Closed Access | Times Cited: 1
Cannabinoid Receptor Type II Ligands from Sandalwood Oil and Synthetic α-Santalol Derivatives
Pradeep Paudel, Pankaj Pandey, Jason J. Paris, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 7, pp. 1786-1792
Closed Access | Times Cited: 1
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1
Emanuele Criscuolo, Maria Laura De Sciscio, Angela De Cristofaro, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 12, pp. 1678-1678
Open Access | Times Cited: 1
Chelation-Tamoxifen Conjugates for Imaging of Estrogen Receptors
Skye Hsin‐Hsien Yeh, Wei-Chung Chang, Shu-Meng Hsu, et al.
Cancer Biotherapy and Radiopharmaceuticals (2021) Vol. 37, Iss. 1, pp. 30-40
Closed Access | Times Cited: 2
Characterization of cannabinoid receptors expressed in Ewing sarcoma TC-71 and A-673 cells as potential targets for anti-cancer drug development
Amal Shoeib, Azure L. Yarbrough, Benjamin M. Ford, et al.
Life Sciences (2021) Vol. 285, pp. 119993-119993
Open Access | Times Cited: 2
Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death
Amal Shoeib, Lance Benson, Shengyu Mu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3049-3049
Open Access | Times Cited: 1
Page 1

Scroll to top